A pioneering Iranian company has developed Tilmanoscept, an innovative nanodrug that promises to transform cancer detection in Iran. This advanced radiopharmaceutical enhances diagnostic accuracy while significantly lowering costs, making it more accessible for patients. Designed for injection alongside imaging scans, Tilmanoscept allows precise identification of cancerous lymph nodes and can scan the entire lymphatic system, benefiting around 90% of cancer patients. With local production ending a US monopoly, the drug reduces lymphatic mapping costs to one-tenth of the global price. As it moves into clinical trials, Tilmanoscept represents a significant advancement in cancer care and positions Iran as a leader in medical technology.
This article will be expanded with more detailed information shortly. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will…
As quantum computers near practical use, experts warn of their potential to render current encryption methods obsolete, threatening military, financial, and personal data security. Scientists are urgently developing quantum-resistant cryptographic tools to counteract vulnerabilities. Quantum computers utilize qubits for efficient calculations, posing significant cybersecurity risks, especially with algorithms like Shor’s that could easily factor large numbers. The U.S. National Institute of Standards and Technology (NIST) is evaluating four post-quantum cryptographic candidates, while researchers explore various strategies to enhance data protection. Proactive measures are crucial, as hackers may store encrypted data for future decryption using quantum technology, highlighting the need for immediate action.
Dr. Nima Nassiri, an Iranian-American surgeon at UCLA, participated in the world’s first successful bladder transplant in California, alongside Dr. Inderbir Gill from USC. The groundbreaking procedure, performed on Oscar Larrainzar, a 41-year-old cancer survivor, allowed him to stop dialysis after previously losing his bladder and kidneys. This innovative transplant offers hope for patients with severe bladder issues, traditionally reliant on less effective reconstructive methods. Both surgeons emphasized the procedure’s significance in revolutionizing treatment options. The patient is recovering well, and further transplants will be conducted as part of a clinical trial to assess long-term outcomes and risks.
Iran is poised to unveil its first radar satellite this year, marking a significant milestone in its space exploration efforts, according to the head of the Iranian Space Agency, Hassan Salarieh. The agency focuses on developing remote sensing and telecommunication satellites, including the Nahid satellite for communication and the Pars series for Earth observation. Progress includes the successful launch of Pars-1 and the upcoming Pars-2. Additionally, two radar satellites, Rad-1 and Rad-2, are in the design phase, aimed at enhancing environmental monitoring, agricultural management, urban planning, and national security. This initiative reflects Iran’s ambition to be a key player in global space technology.
This article will be expanded soon. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly.